Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Frontiers in Immunology|April 15, 2017
Type I Interferons and Natural Killer Cell Regulation in CancerLena Müller, Petra Aigner, Dagmar StoiberCytokine|July 23, 2018
STAT3 isoforms: Alternative fates in cancer?Petra Aigner, Valentin Just, Dagmar StoiberLeukemia & Lymphoma|April 30, 2021
Tumor suppressors in acute myeloid leukemiaJacqueline Wallwitz, Petra Aigner, Dagmar StoiberComparative Migration Studies|October 18, 2021
Organising labour market integration support for refugees in Austria and Sweden during the Covid-19 pandemicAlmina Bešić, Andreas Diedrich, Petra AignerPlos One|August 13, 2019
Validation of an enzyme-linked immunosorbent assay (ELISA) for quantification of endostatin levels in mice as a biomarker of developing glomerulonephritisJacqueline Wallwitz, Petra Aigner, Elisabeth Gadermaier, et al.Acta Biomaterialia|October 4, 2015
Decellularized human placenta chorion matrix as a favorable source of small-diameter vascular graftsKarl Heinrich Schneider, Petra Aigner, Wolfgang Holnthoner, et al.Oncotarget|February 27, 2016
Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic miceEva Bauer, Michaela Schlederer, Ruth Scheicher, et al.Blood Advances|July 5, 2019
STAT3β is a tumor suppressor in acute myeloid leukemiaPetra Aigner, Tatsuaki Mizutani, Jaqueline Horvath, et al.International Journal of Cancer|August 14, 2019
JAK-STAT inhibition impairs K-RAS-driven lung adenocarcinoma progressionJulian Mohrherr, Marcel Haber, Kristina Breitenecker, et al.Science Translational Medicine|June 22, 2018
Afatinib restrains K-RAS-driven lung tumorigenesisHerwig P Moll, Klemens Pranz, Monica Musteanu, et al.Pageof 1